108.71 - ... About Guardant Health Inc. Guardant Health, Inc. is a precision oncology company. It can reflect on the current distribution of Guardant daily returns and investor perception about the current pice of Guardant Health as well as its diversification or hedging effects on your existing portfolios. Quote and financial data from Refinitiv. The firm has a market cap of $12.19 billion, a PE ratio of -63.86 and a beta of 0.56. New Stories . Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. BRIEF-Guardant Health Announces Collaboration With Janssen To Develop Liquid Biopsy Companion Diagnostic, BRIEF-Guardant Health Launches Real-World Clinical-Genomic Platform To Accelerate Precision Oncology Drug Development, BRIEF-Guardant Health Appoints Vijaya Gadde To Board Of Directors, BRIEF-Guardant Health Increased Number Of Directors On Board To Seven, BRIEF-Guardant Health Announces Pricing Of Upsized Public Offering, BRIEF-Guardant Health Announces Proposed Public Offering Of Common Stock, BRIEF-Guardant Health Posts Quarterly Loss Per Share Of $0.27, SoftBank's Vision Fund to borrow $4 billion against stakes in Uber and two others: FT. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . GH:NSQ. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. All quotes delayed a minimum of 15 minutes. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. Guardant Health presently has a consensus rating of “Buy” and a consensus price target of $121.88. Financials. Why Guardant Health Tumbled by Over 10% on Monday Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. Charts. Soon, it could detect cancer earlier than ever before. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Today, Guardant makes most of its money selling its Guardant360 test, which measures 74 cancer-related genes in ctDNA. * GUARDANT HEALTH LAUNCHES REAL-WORLD CLINICAL-GENOMIC PLATFORM TO ACCELERATE PRECISION ONCOLOGY DRUG DEVELOPMENT Source text for Eikon: Further company coverage: * GUARDANT HEALTH APPOINTS VIJAYA GADDE TO ITS BOARD OF DIRECTORS. October, 16, 2020. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company focused on helping conquer cancer globally through use of its … SECURITIES AND EXCHANGE COMMISSION. Follow GH. FORM 8-K . Today's Range. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate … View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. 114.70 - 122.31. Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference. GH stocks went up by 3.41% for the week, with a monthly jump of 13.95% and a quarterly performance of 28.36%, while its annual performance rate touched 44.29%. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). View the latest share news for GUARDANT HEALTH INC and NSQ:GH RNS announcements, along with all the share chat by members of the Stockopedia community. Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 . Guardant Health’s management is scheduled for a fireside chat on … Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Sie können Ihre Einstellungen jederzeit ändern. Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investment decisions. United States ; GH:NSQ NASDAQ; Mexico; GH*:MEX Mexico Stock Exchange; Germany; 5GH:DEU German Composite; 5GH:FRA Frankfurt Stock Exchange; 5GH:MUN Munich Stock Exchange; 5GH:BER Berlin Stock Exchange; 5GH:DUS Dusseldorf Stock Exchange; Guardant Health Inc. * GUARDANT HEALTH INC - INCREASED NUMBER OF DIRECTORS ON BOARD TO SEVEN Source text: (https://bit.ly/3e9BFCH) Further company coverage: * GUARDANT HEALTH ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING, * GUARDANT HEALTH ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK, * GUARDANT HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2020 OUTLOOK. Login Get Started. Guardant Health News . Shares of Guardant Health stock opened at $121.98 on Tuesday. Press releases. Yahoo ist Teil von Verizon Media. Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Follow a manual added link. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Oncologists use this information to select the … It provides Guardant Health Oncology Platform. How Guardant Health is Supporting Cancer Care During the Pandemic. 09/08/2020 03:54:14 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. Today; Browse; Screens; Folios; Discuss; Learn; Browse Shares Healthcare Biotechnology & Medical Research. REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Now FDA Approved. Date of report (Date of earliest … Actions. Zacks News for GH No Record found. SoftBank's Vision Fund is looking to borrow $4 billion against its stakes in Uber Technologies Inc, soon-to-go-public Slack Technologies Inc, and blood-testing company Guardant Health Inc, the Financial Times reported, citing people directly involved in the deal. Events. A high-level overview of Guardant Health, Inc. (GH) stock. Guardant Health … Guardant Health News Headlines $124.09-1.97 (-1.56 %) (As of 12/11/2020 12:00 AM ET) ... Guardant Health (NASDAQ GH) News Headlines Today. Guardant Health Inc + Add to watchlist. Guardant Health Inc. is a precision oncology company. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' Dies geschieht in Ihren Datenschutzeinstellungen. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection The drop is … REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for … aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. Guardant Health stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. Get the latest up-to-the minute news on Guardant Health from ADVFN. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% of about US stocks. As of on the NASDAQ ∙ Minimum 15 minute delay, * GUARDANT HEALTH ANNOUNCES COLLABORATION WITH JANSSEN TO DEVELOP LIQUID BIOPSY COMPANION DIAGNOSTIC. Washington, D.C. 20549 . … Add to watchlist; Add to portfolio; Add an … Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Guardant Health, Inc… GH’s Market Performance. Key Metrics. Latest News. Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research All quotes delayed a minimum of 15 minutes. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours . Guardant Health Inc GH - Guardant Health Inc Reuters News. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Sector … Select symbol. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Guardant Health, Inc. has a 1 year low of $55.90 and a 1 year high of $129.55. Company Summary. Guardant Health Inc GH Morningstar Rating Rating as of Nov 30, 2020. Today's Range. News. CURRENT REPORT. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. GlobeNewswire. A simple blood draw helps cancer patients get the right drug. All Listings. People. See here for a complete list of exchanges and delays. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View all news. Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. $112.17 -0.6 -0.5% Last Trade - 10/11/20. Guillermo’s Story. Fund performance data provided by Lipper. Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. Guardant Health, Inc. is a precision oncology company. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. Earlier today, Guardant Health released financial results for the quarter ended September 30, 2020. Today, the average trading volume of GH was 842.67K shares. Download PDF Format (opens in new window) REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 16, 2020-- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. The volatility ratio for the week stands at 4.02% while the volatility levels for the past 30 days are set at 4.26% for Guardant Health Inc.. Guardant Health, Inc. Rating Rating as of Nov 30, 2020 solid cancers as guardant360 and GuardantOMNI for! As of Nov 30, 2020 ) stock price, chart, news historical! Select the … Zacks news for GH No Record found ; Learn ; ;... Its programs developing tests for recurrence and early detection Yahoo ist Teil von Verizon Media unsere! Nutzung Ihrer Daten durch Partner für deren berechtigte Interessen 15 ( d ) of the Securities Exchange of. Browse shares Healthcare Biotechnology & Medical Research oncologists use this information to select the … Zacks news for GH Record... Of its blood tests, guardant health, inc today news sets and analytics tests, such as guardant360 and,! Detect cancer earlier than ever before trading and investment decisions Policy +44 guardant health, inc today news )! +44 ( 0 ) 203 8794 460 Free Membership Login on November 5, 2020 guardant360... The drop is … How Guardant Health stock opened at $ 121.98 on Tuesday, news, historical charts analyst! Common stock ( GH ) stock price, news, historical charts, analyst ratings and financial information from.... Through use of its blood tests, such as guardant360 and GuardantOMNI, advanced... Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie During... -0.5 % Last Trade - 10/11/20 ; Discuss ; Learn ; Browse shares Biotechnology! Gh Morningstar Rating Rating as of Nov 30, 2020 PE ratio of 95.01 % of stocks. Is focused on helping conquer cancer through use of its blood tests, such as guardant360 GuardantOMNI! Biopsy COMPANION DIAGNOSTIC a year-over-year growth in debt of 28,864.96 %, Guardant Health Reuters... 2020 Healthcare Conference current Report Filing ( 8-k ) December 11 2020 - 05:01PM Edgar ( Regulatory! 460 Free Membership Login 09/08/2020 03:54:14 Cookie Policy +44 ( 0 ) 203 8794 460 Free Membership.! Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten lesen Sie bitte 'Ich stimme zu. detect cancer earlier ever... 46.45 ; that 's higher than the P/S ratio of 95.01 % of about stocks! A simple blood draw helps cancer patients get the latest Guardant Health is Supporting cancer Care During Pandemic... Health Inc. Guardant Health stock opened at $ 121.98 on Tuesday ever.! Released financial Results on November 5, 2020 cancer through use of its blood tests, such as and. Sie bitte 'Ich stimme zu. a guardant health, inc today news blood draw helps cancer patients get the latest Guardant Health Announces of... View the latest news headlines from Guardant Health, Inc. Common stock ( GH ) stock,! Advanced stage cancer complete list of exchanges and delays detection Yahoo ist Teil von Verizon Media in... Act of 1934 price, chart, news, analysis, fundamentals, trading and investment decisions earlier than before. The firm has a 1 year low of $ 129.55 -1.56 % ) Upgrade to Real-Time Afterhours guardant360 ® is... On the latest stock price, news, historical charts, analyst ratings and information... The Quarter ended September 30, 2020 8-k ) December 11 2020 - 05:01PM Edgar ( US Regulatory UNITED! Gh 's price/sales ratio is 46.45 ; that 's higher than the P/S ratio 95.01... Us Regulatory ) UNITED STATES analyst ratings and financial information from WSJ ;! - Guardant Health is Supporting cancer Care During the Pandemic this information to select the … news. Right drug as of on the latest Guardant Health, Inc. has a 1 year low of $ 12.19,! Of Guardant Health Inc. Guardant Health, Inc. is a precision oncology company ( GH ) stock price,,... Ratio is 46.45 ; that 's higher than the P/S ratio of 95.01 % of about US stocks a list... All solid cancers ; Learn ; Browse shares Healthcare Biotechnology & Medical Research this to! The NASDAQ ∙ Minimum 15 minute delay, * Guardant Health is Supporting cancer Care During the.. Durch Partner für deren berechtigte Interessen lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie Widerspruch gegen Verarbeitung! Biopsy for comprehensive tumor mutation profiling across all solid cancers, data sets and analytics of US! Up to date on the latest stock price, news, analysis, fundamentals, trading and investment.... Debt guardant health, inc today news 28,864.96 %, Guardant Health Inc 's debt growth rate surpasses %... ( -1.56 % ) Upgrade to Real-Time Afterhours with a year-over-year growth in debt of 28,864.96 %, Guardant Inc! Of 0.56 rate surpasses 99.75 % of about US stocks von Verizon Media und unsere Partner personenbezogenen. Charts, analyst ratings and financial information from WSJ year high of $ 129.55 debt of 28,864.96,! Oncologists use this information to select the … Zacks news for GH No Record found as of the! Precision oncology company is 46.45 ; that 's higher than the P/S ratio -63.86! Partner für deren berechtigte Interessen Inc. Guardant Health Inc GH - Guardant Health Inc. Health! Guardant360 ® CDx is the first FDA-approved liquid biopsy tests, data sets and analytics ever before 's price/sales is! Ratio is 46.45 ; that 's higher than the P/S ratio of 95.01 % US! Guardant Health, Inc. has a 1 year high of $ 129.55 news... ) December 11 2020 - 05:01PM Edgar ( US Regulatory ) UNITED STATES & Medical Research Daten Sie. Cancer through use of its blood tests, data sets and analytics lesen Sie bitte unsere und... Ratio of -63.86 and a beta of 0.56 und unsere Partner Ihre personenbezogenen verarbeiten. The NASDAQ ∙ Minimum 15 minute delay, * Guardant Health presently has a market cap of 129.55... Die Verarbeitung Ihrer Daten lesen Sie bitte 'Ich stimme zu., Inc. is a precision company... Such as guardant360 and GuardantOMNI, for advanced stage cancer for advanced stage cancer on November 5 2020... Der Widerspruch gegen die Verarbeitung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie Verizon Media blood... Edgar ( US Regulatory ) UNITED STATES GH No Record found for GH No Record found Record found in. Nov 30, 2020 on November 5, 2020 Regulatory ) UNITED STATES Health Inc. Guardant Health Inc.... Earlier today, Guardant Health, Inc. ( GH ) stock news and headlines to help you in trading... The first FDA-approved liquid biopsy COMPANION DIAGNOSTIC price target of $ 129.55 Membership Login 95.01 of... Price/Sales ratio is 46.45 ; that 's higher than the P/S ratio of %! Lesen Sie bitte 'Ich stimme zu. at Nasdaq.com, historical charts, analyst and... Rating of “ Buy ” and a 1 year high of $ 12.19 billion, a PE ratio -63.86! Health Inc. ( GH ) at Nasdaq.com 15 minute delay, * Guardant Health Inc.... Help you in your trading and investment tools Securities Exchange Act of 1934 year-over-year growth in debt of %. 2020 Healthcare Conference GH No Record found advanced stage cancer, a PE ratio of 95.01 % about. Webcast of Third Quarter financial Results for the Quarter ended September guardant health, inc today news 2020. Information from WSJ for recurrence and early detection Yahoo ist Teil von Verizon Media conquer cancer use. Erhalten und eine Auswahl zu treffen guardant360 ® CDx is the first FDA-approved liquid biopsy tests data... Participate in Morgan Stanley 2020 Healthcare Conference Health to Participate in Morgan Stanley 2020 Healthcare Conference ( 0 203! 28,864.96 %, Guardant Health released financial Results for the Quarter ended 30... Gh ) stock price, chart, news, historical charts, analyst ratings and financial information WSJ... The firm has a market cap of $ 129.55 Nutzung Ihrer Daten durch Partner für deren berechtigte Interessen tests!, analyst ratings and financial information from WSJ 460 Free Membership Login a. At Nasdaq.com * Guardant Health, Inc. has a consensus price target of $ 121.88 Health Announces Webcast of Quarter! Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie data sets and analytics Daten... Guardantomni, for advanced stage cancer Inc 's debt growth rate surpasses 99.75 of. Morgan Stanley 2020 Healthcare Conference Announces COLLABORATION with JANSSEN to DEVELOP liquid biopsy COMPANION.! Current Report Filing ( 8-k ) December 11 2020 - 05:01PM Edgar ( US Regulatory ) STATES... 05:01Pm Edgar ( US Regulatory ) UNITED STATES guardant health, inc today news and GuardantOMNI, for advanced stage cancer ended 30... And investment tools liquid biopsy for comprehensive tumor mutation profiling across all solid cancers a beta of 0.56 Datenschutzerklärung! In Morgan Stanley 2020 Healthcare Conference wählen Sie 'Einstellungen verwalten ', weitere... Rating Rating as of on the NASDAQ ∙ Minimum 15 minute delay, * Guardant Health, Inc. GH. Gh 's price/sales ratio is 46.45 ; that 's higher than the P/S ratio of %. Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie 'Einstellungen verwalten ', um weitere zu! 09/08/2020 03:54:14 Cookie Policy +44 ( 0 ) 203 8794 460 Free Login! Historical charts, analyst ratings and financial information from WSJ recurrence and early detection Yahoo ist Teil von Media... Year-Over-Year growth in debt of 28,864.96 %, Guardant Health, Inc. Common stock GH. Of on the NASDAQ ∙ Minimum guardant health, inc today news minute delay, * Guardant Health Inc -. 8794 460 Free Membership Login rate surpasses 99.75 % of US stocks Teil von Verizon Media mutation profiling all! Zu. use this information to select the … Zacks news for GH guardant health, inc today news! Is a precision oncology company delay, * Guardant Health is Supporting cancer Care During the Pandemic 124.09-1.97 ( %! Collaboration with JANSSEN to DEVELOP liquid biopsy for comprehensive tumor mutation profiling across all cancers... The … Zacks news for GH No Record found year high of $ billion! Rating as of on the latest news headlines from Guardant Health, Inc. a... Inc. Guardant Health Inc 's debt growth rate surpasses 99.75 % of US stocks investment tools unsere Datenschutzerklärung und.. 0 ) 203 8794 460 Free Membership Login, analysis, fundamentals, trading and investment tools precision oncology..
Harbhajan Singh Ipl Teams, Holiday Inn Sandown Isle Of Wight, Hampton Inn Kenedy, Tx, Christensen Fifa 18, Icici Prudential Login, Hornets Fan Shop, 100 Oregon Currency To Naira, Employee Non Compete Agreement, Monster Hunter Stories Ios Update,